SAN DIEGO, May 25, 2011 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) will webcast the company's presentation at its Investor Day 2011 to be held on Thursday, May 26, 2011 at the New York Stock Exchange. The webcast will feature presentations by Alan D. Gold, Chairman and Chief Executive Officer, Kent Griffin, President and Chief Operating Officer, and Greg Lubushkin, Chief Financial Officer.
(Logo: http://photos.prnewswire.com/prnh/20091005/BIOMEDLOGO)
The live audio webcast of the presentations and the accompanying slide presentation will be broadcast through a link on BioMed's website, www.biomedrealty.com, from approximately 2:00 p.m. to 3:00 p.m. Eastern Time.
About BioMed Realty Trust
BioMed Realty Trust, Inc. is a real estate investment trust (REIT) focused on Providing Real Estate to the Life Science Industry®. The company's tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. BioMed owns or has interests in 86 properties, representing 148 buildings with approximately 12.3 million rentable square feet. The company's properties are located predominantly in the major U.S. life science markets of Boston, San Diego, San Francisco, Seattle, Maryland, Pennsylvania and New York/New Jersey, which have well-established reputations as centers for scientific research. Additional information is available at www.biomedrealty.com.
SOURCE BioMed Realty Trust, Inc.
Advertisement
(Logo: http://photos.prnewswire.com/prnh/20091005/BIOMEDLOGO)
The live audio webcast of the presentations and the accompanying slide presentation will be broadcast through a link on BioMed's website, www.biomedrealty.com, from approximately 2:00 p.m. to 3:00 p.m. Eastern Time.
Advertisement
About BioMed Realty Trust
BioMed Realty Trust, Inc. is a real estate investment trust (REIT) focused on Providing Real Estate to the Life Science Industry®. The company's tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. BioMed owns or has interests in 86 properties, representing 148 buildings with approximately 12.3 million rentable square feet. The company's properties are located predominantly in the major U.S. life science markets of Boston, San Diego, San Francisco, Seattle, Maryland, Pennsylvania and New York/New Jersey, which have well-established reputations as centers for scientific research. Additional information is available at www.biomedrealty.com.
SOURCE BioMed Realty Trust, Inc.
